期刊文献+

函数法分析AFP和β-hCG在睾丸肿瘤中的变化 被引量:5

Changes of AFP and β-hCG in testicular tumors analyzed by a function method
下载PDF
导出
摘要 目的:建立一种函数法分析AFP和β-hCG在睾丸肿瘤中变化的方法。方法:首先在睾丸根治术后复查AFP和β-hCG并计算其实测值坐标:以癌标实测值的半衰期个数为横坐标,癌标实测值的对数值为纵坐标。其次计算预测值坐标:设术前癌标实测值为a,半衰期个数为x,经过x个半衰期后预测值的对数值为y(以2为底取对数):y=log22axx+y=log2a(公式1),根据公式推导预测值坐标。最后比较癌标实测值与预测值坐标,了解是否有睾丸肿瘤残留或转移。结果:病例1为卵黄囊瘤和合体滋养层细胞的混合性生殖细胞瘤。其AFP和β-hCG在术后第10天的实测值坐标分别为(2.22,6.21)和(10,8.38),预测值坐标分别为(2.22,6.34)和(10,4.41)。该结果提示卵黄囊瘤尚未出现转移,合体滋养层细胞已出现转移。病例2为恶性畸胎瘤和卵黄囊瘤的混合性生殖细胞瘤,其AFP和β-hCG在术后第12天的实测值坐标分别为(2.67,-1.03)和(12,-3.32),预测值坐标分别为(2.67,1.41)和(12,-5.80)。但复查AFP和β-hCG的时间分别为2.67和12个半衰期,超过半衰期有效区间,此时癌标实测值均小于其正常值,可认为肿瘤无残留或转移。病例3为胚胎癌,其AFP在术后第1天的实测值坐标为(0.22,9.25),预测值坐标为(0.22,9.55),该结果提示胚胎癌尚未出现转移。结论:该方法预测的3例患者癌标变化均与实际病程吻合,睾丸根治术后如癌标实测值坐标与预测值坐标吻合,提示肿瘤尚未转移;如不吻合,则提示睾丸肿瘤残留或转移可能。 [Abstract] Objective: To establish a new function method for the analysis of ct-fetoprotein (AFP) and β-hCG in testicular tumors. Methods : We reexamined the serum levels of AFP and β-hCG after radical orchiectomy, and calculated the measured coordi- nate, with the abscissa representing the number of the half-lives of tumor markers, and the ordinate representing the measured value of tumor markers. Referring to the measured value of tumor markers before surgery as a, the number of half-lives as x, and their theoreti- cal value over a period of x elimination half-lives as y ( logarithm to the base 2 of y) , we calculated the predicted coordinate according a to the formula y = log2^2x=x + y = log2 ^&(function 1 ). Then we assessed tumor residue and metastasis by analyzing the relationship be- tween the measured and predicted coordinates. Results : The pathological examination of case 1 revealed a germ cell tumor of a mixed histological pattern of syncytiotrophoblast and yolk sac tumor. The measured coordinates of AFP and β-hCG were (2.22, 6.21 ) and (10, 8.38), and the predicted coordinates (2.22, 6.34) and (10, 4.41 ), indicating the elimination of the yolk sac tumor and me-tastasis of the syncytiotrophoblast tumor. Case 2 demonstrated the mixed pathological nature of teratocarcinoma and yolk sac tumor. The measured coordinates of AFP and 13-hCG were (2.67, - 1.03) and ( 12, -3.32), and the predicted coordinates (2.67, 1.41) and (12, -5.80). But the review times of AFP and β-hCG were out of the effective range of half-lives, with the measured values below the normal, which suggested no tumor residue or metastasis. Case 3 was found to be embryonal carcinoma. The measured coordinate of AFP was (0.22, 9.25), and the predicted coordinate (0.22, 9.55), indicating the elimination of tumor. Conclusion : The change of the tumor markers predicted by the function method coincided with the natural course of disease in the three cases. The coincidence of the measured with the predicted coordinate after radical orchiectomy indicates no metastasis, while their disagreement suggests possi- ble residue and metastasis of the tumor.
出处 《中华男科学杂志》 CAS CSCD 2013年第1期59-62,共4页 National Journal of Andrology
关键词 睾丸肿瘤 甲胎蛋白 人绒毛膜促性腺激素 函数法 testicular tumor ct-fetoprotein p-human chorionic gonadotropin function method
  • 相关文献

参考文献7

  • 1Doherty AP,Bower M,Christmas TJ. The role of tumor markers in the diagnosis and treatment of testicular germ cell cancers[J].British Journal of Urology,1997,(02):247-252.
  • 2关晓峰,刘启明,周德雄,李飞,杨玉恺,王华毅,邓耀良.睾丸混合性生殖细胞瘤1例报告[J].中华男科学杂志,2010,16(9):853-855. 被引量:4
  • 3Albers P,Albrecht W,Algaba F. Guidelines on testicular cancer[J].European Urology,2005,(06):885-894.doi:10.1016/j.eururo.2005.06.019.
  • 4那彦群;叶章群;孙光.中国泌尿外科疾病诊断治疗指南[M]北京:人民卫生出版社,201187-88.
  • 5Olofsson SE,Tandstad T,Jerkeman M. Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor:A report from the Swedish-Norwegian testicular cancer group[J].Journal of Clinical Oncology,2011,(15):2032-2039.
  • 6Choe SC,Zhao G,Zhao Z. Model for in vivo progression of tumors based on co-evolving cell population and vasculature[J].Sci Rep,2011.31.
  • 7Steyerberg EW,Pencina M J,Lingsma HF. Assessing the incremental value of diagnostic and prognostic markers:A review and illustration[J].European Journal of Clinical Investigation,2012,(02):216-228.

二级参考文献11

  • 1马鑫,张旭,李宏召,郑涛,张军,傅斌,郎斌,许凯.腹腔镜腹膜后淋巴结清扫术9例报告[J].中国微创外科杂志,2005,5(6):421-423. 被引量:11
  • 2吴刚,杨华,靳风烁,李黔生,朱方强,江军.睾丸纯绒癌2例报告并文献复习[J].临床泌尿外科杂志,2006,21(9):667-669. 被引量:5
  • 3王为服,常乐,Suks Minhas,David Ralph.2005年第100届美国泌尿科学会年会纪要[J].中华男科学杂志,2007,13(3):277-279. 被引量:3
  • 4吴阶平.吴阶平泌尿外科学.济南:山东科学技术出版社,2008:786.
  • 5Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: A review. J Urol, 2003, 170( 1 ) : 5- 11.
  • 6Albers P, Albrecht W, Algaba F, et al. Guidelines on testicular cancer. Eur Urol, 2005, 48(6) : 885-894.
  • 7Javadpour N. The role of biologic tumor markers in testicular cancer. Cancer, 1980, 45(7 Suppl) : 1755-1761.
  • 8Resnick MI编著.叶章群,孙西钊,潘铁军,等译,泌尿外科关键决策.北京:科学出版社,2007.246-247.
  • 9Doherty AP, Bower M, Christmas TJ. The role of tumour markers in the diagnosis and treatment of testicular germ ceil cancers. Br J Urol, 1997, 79(2) : 247-252.
  • 10Spermon JR, Kiemeney LA, Meuleman EJ, et al. Fertility in men with testicular germ cell tumors. Fertil Steril, 2003, 79 ( Suppl 3) : 1543-1549.

共引文献3

同被引文献33

  • 1周爱萍,王金万,冯奉仪,石远凯,杨林.HCG和(或)β-HCG在睾丸精原细胞瘤中的价值[J].医学研究通讯,2004,33(8):8-10. 被引量:1
  • 2张朋,曾浩,卢一平,远洋,李虹.睾丸生殖细胞肿瘤176例临床诊治分析[J].中华男科学杂志,2006,12(3):237-239. 被引量:5
  • 3Sternberg SS(回允中译).诊断外科病理学.第3版,北京:北京大学医学出版社,2003:2220-2221.
  • 4吴阶平.泌尿外科学[M].济南:山东科学技术出版社,2000.374-379.
  • 5王家良 刘鸣.循证医学[M].北京:人民卫生出版社,2001.177-188.
  • 6Date H. Diagnostic strategies for mediastinal tumors and cysts [J]. Torac Surg Clin, 2009, 19(1): 29-35.
  • 7Ackman JB. MR Imaging of Mediastinal Masses[ J]. Magn Reson Imaging Clin N Am, 2015, 23(2) : 141-164.
  • 8Zhang K, Deng H, Cagle PT. Utility of immunohistochemistry in the diagnosis of pleuropulmonary and mediastinal cancers : areview and update[Jl. Arch Pathol Lab Med, 2014, 138(12) : 1611- 1628.
  • 9Takizawa A, Kishida T, Miura T, et al. Clinical effectiveness of t of serum total human chorionic gonadotropin for diagnosis and management of testicular seminomatous germ cell tumor[J]. Hinyokika Kiyo, 2012, 58(3) : 137-142.
  • 10Bonet AS, Muoz-Delgado EG, Vico FJ, et al. Analysis of clinical pathologic variables, staging and prognostic groups, and therapeutic results of 106 germ-cell testicular tumors [ J ]. Arch Esp Urol, 2011,64(10) : 972-980.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部